IRAK1 and pancreatic neoplasm: In pancreatic cancer cells, miR-146a inhibits the invasive capacity with concomitant down-regulation of EGFR and the NF-kappaB regulatory kinase, interleukin 1 receptor-associated kinase 1 (IRAK-1) [8].